Phibro Animal Health Corporation Reports Fourth Quarter and Fiscal Year
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
Phibro Animal Health Corp. (PAHC) PT Lowered to $41 at Piper Jaffray; Reiterates Overweight
September 1, 2017 10:04 AM EDTPiper Jaffray lowered its price target on Phibro Animal Health Corp. (NASDAQ: PAHC) to $41.00 (from $42.00) while maintaining a Overweight rating following the company's 4Q. PAHC reported top and bottom line upside, where revenue of $195M came in above the Street at $192.5M and adjusted... More



